U.S. markets open in 38 minutes
  • S&P Futures

    4,403.25
    +8.50 (+0.19%)
     
  • Dow Futures

    34,745.00
    +55.00 (+0.16%)
     
  • Nasdaq Futures

    15,099.25
    +25.75 (+0.17%)
     
  • Russell 2000 Futures

    2,198.40
    +6.70 (+0.31%)
     
  • Crude Oil

    68.57
    +0.42 (+0.62%)
     
  • Gold

    1,813.90
    -0.60 (-0.03%)
     
  • Silver

    25.50
    +0.04 (+0.15%)
     
  • EUR/USD

    1.1841
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    1.1790
    -0.0050 (-0.42%)
     
  • Vix

    17.64
    -0.40 (-2.22%)
     
  • GBP/USD

    1.3909
    +0.0025 (+0.18%)
     
  • USD/JPY

    109.5870
    +0.1190 (+0.11%)
     
  • BTC-USD

    37,550.08
    -1,003.16 (-2.60%)
     
  • CMC Crypto 200

    928.39
    +1.62 (+0.18%)
     
  • FTSE 100

    7,116.59
    -7.27 (-0.10%)
     
  • Nikkei 225

    27,728.12
    +144.04 (+0.52%)
     

With EPS Growth And More, Genpact (NYSE:G) Is Interesting

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses.

So if you're like me, you might be more interested in profitable, growing companies, like Genpact (NYSE:G). Now, I'm not saying that the stock is necessarily undervalued today; but I can't shake an appreciation for the profitability of the business itself. In comparison, loss making companies act like a sponge for capital - but unlike such a sponge they do not always produce something when squeezed.

View our latest analysis for Genpact

Genpact's Earnings Per Share Are Growing.

If you believe that markets are even vaguely efficient, then over the long term you'd expect a company's share price to follow its earnings per share (EPS). It's no surprise, then, that I like to invest in companies with EPS growth. Over the last three years, Genpact has grown EPS by 7.5% per year. That might not be particularly high growth, but it does show that per-share earnings are moving steadily in the right direction.

One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. While we note Genpact's EBIT margins were flat over the last year, revenue grew by a solid 12% to US$3.7b. That's a real positive.

In the chart below, you can see how the company has grown earnings, and revenue, over time. Click on the chart to see the exact numbers.

earnings-and-revenue-history
earnings-and-revenue-history

You don't drive with your eyes on the rear-view mirror, so you might be more interested in this free report showing analyst forecasts for Genpact's future profits.

Are Genpact Insiders Aligned With All Shareholders?

Since Genpact has a market capitalization of US$7.3b, we wouldn't expect insiders to hold a large percentage of shares. But we are reassured by the fact they have invested in the company. Indeed, they hold US$42m worth of its stock. That shows significant buy-in, and may indicate conviction in the business strategy. Despite being just 0.6% of the company, the value of that investment is enough to show insiders have plenty riding on the venture.

Is Genpact Worth Keeping An Eye On?

As I already mentioned, Genpact is a growing business, which is what I like to see. Just as polish makes silverware pop, the high level of insider ownership enhances my enthusiasm for this growth. That combination appeals to me, for one. So yes, I do think the stock is worth keeping an eye on. What about risks? Every company has them, and we've spotted 2 warning signs for Genpact you should know about.

You can invest in any company you want. But if you prefer to focus on stocks that have demonstrated insider buying, here is a list of companies with insider buying in the last three months.

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.